The Neurogenesis and Antidepressants Experiment – René Hen

The quest to decipher the biological foundations of affective disorders has long oscillated between neurochemical reductions and architectural models of brain plasticity. For decades, the dominant clinical framework for major depressive disorder was the monoamine hypothesis, which posited that depressive states stem primarily from a functional deficiency in central monoaminergic neurotransmission, particularly serotonin and norepinephrine. While this hypothesis catalyzed the synthesis of several generations of pharmacotherapies—from monoamine oxidase inhibitors and tricyclics to selective serotonin reuptake inhibitors (SSRIs)—it harbored a profound, unresolved paradox. Although these therapeutic agents alter synaptic monoamine concentrations within hours of administration, patients typically experience a therapeutic delay of several weeks or even months before exhibiting meaningful clinical remission. This temporal divergence suggested that acute monoaminergic elevation is merely the initial trigger in a downstream cascade of neurobiological adaptations.

In 2003, a watershed study published in Science by René Hen and his research group at Columbia University, spearheaded by lead author Luca Santarelli, fundamentally reframed the biological narrative of antidepressant efficacy. Rather than viewing the therapeutic outcome as an immediate consequence of heightened synaptic monoamine levels, Hen’s team proposed that the behavioral recovery elicited by chronic antidepressant treatment is causally dependent upon adult hippocampal neurogenesis—the lifelong generation, maturation, and functional integration of new neurons in the subgranular zone of the dentate gyrus. By coupling targeted focal cranial X-irradiation with sophisticated ethological assays, Hen and his colleagues established that abolishing neurogenesis in the adult mammalian brain directly blunted the anxiolytic and antidepressant-like responses to classic antidepressant agents.

This landmark investigation challenged the static view of the adult brain as an immutable circuit and elevated the concept of structural neuroplasticity to the forefront of psychiatric neuroscience. It provided a direct, mechanistically grounded cellular clock that cleanly explained the clinical latency characterizing pharmacological interventions. The following analysis explores the architecture, execution, and enduring legacy of the René Hen experiment, tracing the intellectual trajectory from early neurogenic heresies to contemporary optogenetic dissection of the dentate microcircuit.

1. Introduction to Adult Neurogenesis and René Hen’s Landmark Breakthrough

The realization that the adult mammalian brain generates functional new neurons throughout life represents one of the most consequential paradigm shifts in modern neurobiology. To appreciate the magnitude of René Hen’s contribution, one must first examine the historical entrenchment of neurobiological dogma, the pioneering methodologies that overturned it, and the precise anatomical niche within the hippocampal formation where this continuous neurodevelopment unfolds.

1.1 The Evolution of the Neurogenesis Dogma in Adult Mammalian Brains

For nearly a century, central nervous system biology operated under the unyielding doctrine codified by the father of modern neuroscience, Santiago Ramón y Cajal. Cajal famously postulated that in the adult brain, neural pathways are fixed, immutable, and terminated: everything may die, but nothing may be regenerated. This doctrine established a conceptual orthodoxy that relegated neurogenesis exclusively to embryonic and early postnatal developmental windows. The adult brain was understood to maintain function strictly through synaptic modifications among a static population of post-mitotic neurons, leaving no conceptual room for the de novo production of functional parenchymal cells.

The first significant empirical challenges to this dogma arose during the 1960s through the work of Joseph Altman at the Massachusetts Institute of Technology. Utilizing tritiated thymidine ([³H]-thymidine) autoradiography—a technique wherein radioactive thymidine is incorporated into the synthesizing DNA of cells undergoing mitotic division—Altman published evidence of ongoing cell proliferation within the adult rodent neocortex, olfactory bulb, and the dentate gyrus of the hippocampus. Despite meticulous histological preparations, Altman’s findings were largely dismissed by contemporary neuroanatomists as artifactual labeling of glial cells or pathological cellular repair. Decades later, Michael Kaplan confirmed these observations through electron microscopy, unequivocally documenting that cells incorporating [³H]-thymidine exhibited the ultrastructural hallmarks of genuine neurons, including dendritic processes, neurofilaments, and synaptic junctions. Nonetheless, the prevailing scientific climate remained skeptical.

It was not until the 1990s that the neurogenic paradigm gained decisive empirical validation, catalyzed by the methodological innovations of researchers such as Fred Gage and Elizabeth Gould. The field shifted significantly with the advent of 5-bromo-2′-deoxyuridine (BrdU), a non-radioactive thymidine analog that could be visualized through phenotypic fluorescent immunohistochemistry and multi-channel confocal microscopy. Gage, Gould, and their colleagues conclusively demonstrated that adult neurogenesis occurs robustly within the subgranular zone of the mammalian dentate gyrus and the subventricular zone of the lateral ventricles across multiple species, including non-human primates and human subjects. With the structural existence of adult neurogenesis unequivocally confirmed, the neuroscientific community arrived at an urgent conceptual pivot: determining the precise functional, cognitive, and psychiatric relevance of these newborn neurons in the mature brain.

1.2 René Hen’s Conceptual Premise: Linking Plasticity to Mood Regulation

As the morphological reality of adult neurogenesis crystallized, psychiatric pharmacology found itself in an explanatory crisis regarding the treatment of major depressive disorder (MDD). Clinicians had long recognized that while monoaminergic reuptake inhibitors like fluoxetine or imipramine bind to their respective transmembrane transporters within minutes, therapeutic relief from depressive symptoms consistently requires three to six weeks of uninterrupted pharmacological exposure. This pervasive latency indicated that the therapeutic agent was not merely substituting for a deficient neurotransmitter, but was instead triggering a complex, gradual biological program of structural plasticity.

René Hen, working in the Department of Pharmacology and the Center for Neurobiology and Behavior at Columbia University, recognized a compelling temporal convergence. The time required for newly born neural progenitors in the dentate gyrus to divide, differentiate, migrate, extend axonal projections, and synaptically integrate into the hippocampal trisynaptic circuit spans precisely several weeks—a period directly mirroring the delayed onset of clinical antidepressant action. Hen hypothesized that cellular proliferation and subsequent neural maturation within the hippocampus, rather than acute elevation of extracellular monoamines, served as the mandatory downstream cellular substrate through which antidepressants exert their emotional and behavioral actions.

To test this postulate, Hen recognized that simple correlative observations—such as measuring increased rates of neurogenesis alongside reduced behavioral despair—would be fundamentally insufficient to establish biological truth. A definitive mechanistic claim demanded a rigorous demonstration of necessity through loss-of-function experiments. Hen formulated an ambitious experimental architecture that combined refined genetic mouse models, standardized chronic psychopharmacological regimens, precision radiological ablation, and ethologically grounded behavioral paradigms. By selectively disrupting adult hippocampal neurogenesis while leaving the surrounding central nervous system intact, Hen set out to test whether adult-born neurons were a secondary epiphenomenon or the non-negotiable biological bridge linking monoamine reuptake inhibition to behavioral recovery.

1.3 The Significance of the Dentate Gyrus as a Neurogenic Niche

The hippocampal formation is uniquely situated at the crossroads of cognitive processing, spatial representation, and emotional regulation. Within this archicortical structure, the dentate gyrus serves as the primary gateway, receiving major excitatory afferents from the entorhinal cortex via the perforant path and projecting onward to the CA3 pyramidal cell field via unmyelinated mossy fiber axons. The subgranular zone (SGZ)—a narrow, two- to three-cell-layer-thick band residing directly at the interface of the granule cell layer and the polymorphic hilus—constitutes one of the few privileged microenvironments in the adult mammalian brain capable of sustaining lifelong neurogenesis.

Within this specialized neurogenic niche, a finely orchestrated developmental cascade unfolds. The process originates from multipotent, quiescent radial glia-like stem cells (classified as Type-1 progenitors). These Type-1 cells express specific astrocytic markers, such as glial fibrillary acidic protein (GFAP) and Nestin, and possess long apical processes that traverse the granule cell layer to sample signals within the molecular layer. Upon activation, Type-1 cells undergo asymmetric division to yield intermediate neural progenitor cells (classified as Type-2 progenitors). Type-2 cells represent an actively amplifying population characterized by high rates of mitotic division and the expression of transcription factors such as Sox2 and Tbr2. These intermediate cells subsequently transition into neuroblasts (Type-3 cells), exit the cell cycle, and express the microtubule-associated protein doublecortin (DCX) as they undergo neuronal differentiation into immature granule neurons.

Crucially, the dentate gyrus is an anatomical hub for neuroendocrine integration, exhibiting an extraordinarily high density of corticosteroid receptors and monoaminergic terminals. This dense vascular, neurochemical, and glia-rich microenvironment makes the SGZ exquisitely sensitive to environmental disruptions. Systemic stressors, systemic inflammation, and prolonged neuroendocrine activation profoundly suppress SGZ cellular mitosis, whereas environmental enrichment, physical exercise, and psychotropic compounds upregulate cell proliferation. The dentate gyrus thereby functions as an adaptive, biological transducer, converting exogenous psychosocial and chemical inputs into structural modifications of the hippocampal circuit.

2. Historical Context: From the Monoamine Hypothesis to Cellular Plasticity

The transition from a neurochemical-deficiency paradigm of affective illness to a structural plasticity model required an extensive reevaluation of clinical, radiological, and molecular data. To contextualize the significance of Hen’s 2003 breakthrough, one must examine the empirical failures of the classical monoamine model and the parallel emergence of the neurotrophic hypothesis of depression.

2.1 The Explanatory Limitations of the Classical Monoamine Model

Formulated in the mid-1960s by Joseph Schildkraut and Alec Coppen, the monoamine hypothesis posited that depressive pathology arose from depleted functional concentrations of serotonin (5-hydroxytryptamine, or 5-HT) and norepinephrine in critical central limbic pathways. This formulation was largely inferred from serendipitous pharmacological discoveries: the antihypertensive agent reserpine, which depletes vesicular monoamines, occasionally induced profound depressive states, whereas iproniazid, a monoamine oxidase inhibitor, and imipramine, a tricyclic reuptake blocker, alleviated clinical symptoms. For decades, this neurochemical deficit model served as the foundational blueprint for academic psychopharmacology and industrial drug development.

Despite its intuitive elegance, the monoamine hypothesis accumulated fatal empirical inconsistencies. Most prominent was the irreconcilable pharmacokinetic paradox: SSRIs and tricyclics achieve maximal blockade of monoamine reuptake transporters within two hours of oral administration, causing an immediate, sustained surge of extracellular monoamines in the synaptic cleft. Yet, substantial mood elevation and clinical recovery invariably require three to eight weeks of continuous daily administration. If depression were merely a straightforward deficit of synaptic monoamines, clinical remission should theoretically manifest concurrently with the acute pharmacological reuptake inhibition.

Furthermore, controlled clinical studies systematically failed to confirm that monoamine depletion reliably triggers depressive symptoms in healthy human volunteers. Paradigm protocols employing acute dietary tryptophan depletion—which reduces central serotonin synthesis by over 80% within hours—consistently failed to induce affective pathology in individuals lacking a genetic or clinical vulnerability to mood disorders. Similarly, post-mortem analyses of brain tissue from suicide victims and depressed individuals failed to yield uniform, reproducible abnormalities in central monoamine concentrations or receptor densities. These collective anomalies demonstrated that monoamine deficiency was neither necessary nor sufficient to induce clinical depression, prompting researchers to seek downstream neurobiological mechanisms capable of operating on a multi-week timescale.

2.2 Stress-Induced Atrophy and the Neurotrophic Hypothesis

Concurrently with the declining explanatory power of the monoamine hypothesis, clinical neuroimaging yielded structural insights into the neuropathology of major depressive disorder. High-resolution magnetic resonance imaging (MRI) studies directed by Yvette Sheline and J. Douglas Bremner documented measurable, bilateral volumetric reductions within the hippocampus of patients suffering from unipolar recurrent depression. Crucially, the magnitude of this hippocampal volume loss correlated directly with the cumulative duration of untreated depressive episodes. Post-mortem stereological analyses corroborated these findings, demonstrating significant reductions in neuropil volume, dendritic arborization, and synaptic density within the hippocampal formation, rather than widespread, necrotic cell loss.

These structural findings aligned closely with pre-clinical models of chronic psychosocial stress pioneered by Robert Sapolsky and Bruce McEwen. Sustained activation of the hypothalamic-pituitary-adrenal (HPA) axis induces prolonged elevations of systemic glucocorticoids (principally cortisol in humans and corticosterone in rodents). Excess glucocorticoid receptor activation in the hippocampus impairs astrocytic glutamate reuptake, triggering sustained, low-grade excitotoxicity that prompts dendritic retraction, spine elimination, and marked suppression of progenitor proliferation in the subgranular zone. Chronic stress essentially strips the hippocampus of its architectural complexity, eroding its capacity to dynamically modulate emotional output.

In response to these discoveries, the neurotrophic hypothesis of depression was formulated, primarily championed by Ronald Duman and his colleagues at Yale University. Duman proposed that major depressive episodes are driven by a failure of neurotrophic factor support—most notably brain-derived neurotrophic factor (BDNF)—leading to cellular atrophy and structural regression in vulnerable limbic structures. Duman demonstrated that chronic, but not acute, administration of diverse classes of antidepressant drugs (including SSRIs, tricyclics, and electroconvulsive seizures) directly upregulates BDNF transcription and its high-affinity receptor, tropomyosin receptor kinase B (TrkB), within the hippocampus. This neurotrophic surge reversed stress-induced dendritic atrophy, providing a biological mechanism through which prolonged pharmacological treatment could structurally remodel aberrant neural circuits.

2.3 The Search for Causality: Correlation Versus Necessity

By the turn of the millennium, independent investigations by Ronald Duman, Barry Jacobs, and Jessica Malberg had documented a consistent empirical correlation: chronic antidepressant treatment reliably increases BrdU incorporation in the adult rodent subgranular zone, stimulating both progenitor cell division and long-term newborn neuron survival. Parallel studies demonstrated that diverse therapeutic modalities, including selective norepinephrine reuptake inhibitors, physical wheel running, and enriched environmental housing, uniformly elevated dentate neurogenic markers. Stress predictably suppressed neurogenesis, while therapeutic interventions robustly stimulated it.

However, an acute scientific challenge remained unaddressed: establishing whether adult neurogenesis was functionally required for antidepressant responses, or whether it represented a secondary, epiphenomenal biomarker of elevated trophic signaling. In biological sciences, demonstrating that phenomenon A (enhanced neurogenesis) correlates with phenomenon B (alleviated behavioral despair) does not establish that A causes B. It remained entirely plausible that antidepressants exert their behavioral effects via parallel, non-neurogenic pathways—such as modulating mature neocortical pyramidal spine dynamics, regulating local interneuron excitability, or altering epigenetic chromatin architecture—while hippocampal neurogenesis occurred merely as an incidental bystander effect of monoaminergic elevation.

Resolving this challenge required an uncompromising causal design. If adult-born neurons were truly the indispensable mechanistic link mediating clinical recovery, then the targeted, selective elimination of adult neurogenesis must completely block the behavioral actions of chronic antidepressant administration. If behavioral recovery persisted despite the total ablation of new neuron generation, the neurogenic hypothesis of antidepressant action would be decisively falsified. This was the fundamental experimental mandate that René Hen, Luca Santarelli, and their collaborators set out to resolve in their 2003 investigation.

3. The Architecture of the 2003 Santarelli and Hen Study

To definitively address the causality question, the experimental design had to isolate adult neurogenesis as the single operational variable. Hen and Santarelli developed an interdisciplinary protocol combining mouse genetics, chronic pharmacological exposure, and rigorous environmental standardization to eliminate experimental artifacts.

3.1 Experimental Cohorts, Mouse Strains, and Behavioral Standardization

The foundation of the study rested on the strategic selection of inbred rodent genetic backgrounds. René Hen utilized two well-characterized mouse strains exhibiting divergent emotionality, neuroendocrine reactivity, and baseline rates of adult neurogenesis: the 129SvEv and C57BL/6 strains. The 129SvEv strain is characterized by heightened baseline emotionality, high anxiety-like phenotypes in novel environments, and low stress resilience, making it a robust behavioral model for assessing anxiolytic and antidepressant efficacy. Conversely, the C57BL/6 strain exhibits higher baseline exploratory drive, lower stress-induced suppression of neurogenesis, and altered sensitivity to specific psychotropic agents. By conducting identical experimental protocols in both strains, the investigators ensured that their findings were not an artifact of a single idiosyncratic genetic background, but reflected a generalizable neurobiological principle.

Behavioral standardization required absolute control over ambient environmental factors capable of influencing adult neurogenesis. Physical activity—such as voluntary access to running wheels—is one of the most potent non-pharmacological stimulators of progenitor cell mitosis in the subgranular zone. Similarly, complex environmental enrichment protocols alter neurogenic rates and hippocampal neurotrophin expression. Consequently, all animal cohorts were housed under strictly controlled pathogen-free conditions with fixed 12-hour light/dark cycles, constant ambient temperatures, and uniform barren caging devoid of running wheels, climbing structures, or sensory enrichment objects.

Furthermore, the experimental timeline was structured to cleanly contrast acute versus chronic pharmacological regimens. Mice were randomized into cohorts receiving vehicle or active compounds for short-term windows (ranging from 1 to 5 days) or sustained long-term regimens lasting 28 continuous days. This temporal stratification was critical: it allowed the researchers to mirror the human clinical therapeutic timeline and determine whether behavioral changes aligned precisely with the multi-week kinetic maturation profile of adult-born dentate granule neurons.

3.2 Pharmacological Paradigms: SSRIs and Tricyclic Antidepressants

To ensure that the observed behavioral and cellular findings were not restricted to a single chemical entity, Hen’s paradigm investigated two structurally and pharmacologically distinct classes of classic antidepressants: the selective serotonin reuptake inhibitor (SSRI) fluoxetine and the tricyclic antidepressant (TCA) imipramine. Fluoxetine functions through high-affinity competitive inhibition of the serotonin transporter (SERT, encoded by SLC6A4), selectively elevating extracellular 5-HT levels in synaptic terminals. Imipramine, by contrast, acts as a dual inhibitor of both the serotonin transporter and the norepinephrine transporter (NET, encoded by SLC6A2), while concurrently displaying antagonist properties at several post-synaptic monoaminergic and cholinergic receptors.

A critical consideration was maintaining stable, pharmacologically relevant systemic drug concentrations across the multi-week experimental duration. Rodents metabolize antidepressant compounds at rates substantially higher than humans. To circumvent the stress and acute neuroendocrine spikes associated with daily repetitive oral gavage or manual intraperitoneal injections, drugs were continuously administered either through calibrated drinking water solutions adjusted daily for body weight and liquid consumption, or via surgically implanted subcutaneous osmotic minipumps. Liquid concentrations were calibrated to achieve steady-state serum levels of fluoxetine and imipramine equivalent to those observed in human patients undergoing sustained psychiatric treatment (approximately 15–20 mg/kg/day for rodents).

This dual-pharmacological approach was methodologically indispensable. Demonstrating that both an SSRI (fluoxetine) and a TCA (imipramine) required intact neurogenesis to exert their behavioral effects would prove that the neurogenic requirement was not an isolated quirk of serotonin reuptake blockade, but represented a convergent downstream pathway utilized by diverse classes of monoamine-modulating agents.

3.3 Defining the Core Hypothesis Tested by the Hen Laboratory

The core scientific hypothesis tested by René Hen and his team was both elegant and unambiguous: adult hippocampal neurogenesis is a mandatory cellular prerequisite for the behavioral responses elicited by chronic antidepressant pharmacotherapy. This primary hypothesis generated several explicit, falsifiable mechanistic predictions:

• Temporal Dependency: If newly generated neurons are the functional mediators, behavioral recovery will not manifest under acute administration, but will require a minimum chronic administration period (28 days) sufficient for newly born post-mitotic neuroblasts to mature and synaptically integrate.
• Proliferation Versus Survival: Antidepressants must do more than acutely elevate transient cell division; they must actively support the long-term survival, morphological differentiation, and circuit incorporation of adult-born dentate granule cells.
• Ablation-Induced Insensitivity: If neurogenesis is selectively eliminated within the hippocampus, chronic administration of fluoxetine or imipramine will completely fail to elicit behavioral improvements in ethological assays sensitive to chronic antidepressant action, despite normal systemic drug concentrations and unaffected acute monoaminergic signaling.

By framing the hypothesis in strictly causal terms, Hen established a rigorous experimental framework. The central scientific burden became developing a methodology capable of selectively ablating adult hippocampal neurogenesis with surgical anatomical precision, avoiding generalized cytotoxic destruction or global neuroinflammatory disruption.

4. Methodological Ingenuity: Targeted Hippocampal X-Irradiation

The technological innovation that distinguished the 2003 Santarelli and Hen study was the application of low-dose, focal stereotaxic cranial irradiation. Rather than relying on non-specific systemic anti-mitotic chemotherapeutic agents, which cause widespread peripheral organ failure and generalized central neurotoxicity, the Hen laboratory utilized targeted X-irradiation to ablate neurogenesis within an isolated anatomical locus.

4.1 The Mechanics of Focal Low-Dose Cranial Irradiation

Rapidly cycling progenitor cells exhibit extreme vulnerability to ionizing radiation due to the induction of double-strand DNA breaks during the S-phase of the cell cycle, which reliably triggers p53-dependent apoptotic death. Post-mitotic mature neurons, glia, and vascular structures, possessing low baseline mitotic activity, remain highly resistant to equivalent fractional doses of ionizing radiation. Hen leveraged this biological disparity to selectively eliminate proliferating progenitors while preserving mature parenchymal architecture.

To prevent broad neurological damage, the team designed precision stereotaxic lead shields. Anesthetized mice were positioned in custom stereotaxic immobilization frames beneath a heavy lead apparatus (typically 3–4 mm in thickness) capable of blocking more than 99% of incoming X-ray photons. A micro-machined, high-tolerance rectangular aperture was cut into the lead shield, positioned to align with the stereotaxic coordinates of the dorsal and ventral hippocampus. Ionizing radiation was directed through this aperture, delivering a calibrated fractionated dose (typically two to three fractionated exposures of 5 to 7.5 Gray, totaling roughly 15 Gy) across consecutive days.

This localized, fractionated dosing regimen produced sustained mitotic arrest within the subgranular zone without triggering broad tissue necrosis, gross demyelination, or extensive microvascular collapse. Progenitor cells attempting mitotic division underwent rapid apoptosis, whereas mature, fully differentiated hippocampal granule cells and CA1/CA3 pyramidal neurons retained their baseline electrophysiological viability and anatomical integrity.

4.2 Control Paradigms: Subventricular Zone and Olfactory Bulb Integrity

A primary methodological challenge in cranial irradiation studies is ensuring anatomical specificity. The mammalian brain contains a second major neurogenic niche: the subventricular zone (SVZ) bordering the lateral ventricles. Neuroblasts generated in the SVZ migrate anteriorly along the rostral migratory stream (RMS) to replenish granule cells and periglomerular interneurons within the main olfactory bulb. Disruption of SVZ neurogenesis impairs olfactory discrimination, which could severely confound performance in rodent behavioral tasks that rely on food foraging and olfactory sensory processing.

Hen implemented rigorous anatomical shielding to prevent incidental exposure of the SVZ and anterior forebrain. By restricting the radiation field to the caudal coordinates corresponding to the hippocampus, the SVZ remained fully shielded behind lead plates. Post-experimental histology confirmed that while the subgranular zone of the dentate gyrus was completely depleted of mitotic progenitors, the SVZ and the rostral migratory stream maintained normal cellular density and proliferative activity.

To confirm that shielded animals retained intact sensory and motor faculties, Hen conducted a series of functional control paradigms. Irradiated mice underwent comprehensive olfactory habituation/dishabituation assays and buried food tests; their latency to locate hidden, familiar food pellets was indistinguishable from non-irradiated sham controls. Furthermore, open field locomotor tracking, rotarod motor coordination, and baseline sensory reflexes showed no divergence between irradiated and sham cohorts. These control assays demonstrated that behavioral differences observed in subsequent emotional tests could not be attributed to radiation-induced sensory degradation, generalized cognitive blunting, or motor ataxia.

4.3 Histological Validation via Molecular Markers

To definitively verify the cellular consequences of the irradiation protocol, the investigators conducted quantitative immunohistochemical phenotyping utilizing endogenous and exogenous proliferative markers.

Exogenous tracking was performed via 5-bromo-2′-deoxyuridine (BrdU) pulse-chase protocols. Mice received systemic intraperitoneal injections of BrdU, which incorporates into synthesizing DNA. Confocal stereological quantification was conducted across the entire rostrocaudal extent of the dentate gyrus. In sham-irradiated mice treated with chronic antidepressants, the subgranular zone showed robust populations of BrdU-positive nuclei, indicative of elevated cell division. In contrast, hippocampal-irradiated cohorts exhibited a near-total loss (>85–95%) of BrdU-labeled cells in the dentate gyrus, confirming that the fractionated X-ray regimen had successfully ablated progenitor mitosis.

To substantiate the BrdU data, endogenous cell cycle and maturation markers were assessed:

• Ki-67: An endogenous nuclear protein expressed strictly during active phases of the cell cycle (G1, S, G2, and M) and absent in quiescent G0 cells. Ki-67 immunohistochemistry confirmed the sustained depletion of cycling progenitors in the irradiated subgranular zone.
• Doublecortin (DCX): A microtubule-associated phosphoprotein transiently expressed in migrating neuroblasts and immature granule neurons during their first two to three weeks of life. Chronic antidepressant treatment produced an expansion of DCX-positive cell bodies and dendritic processes in sham animals, whereas irradiated cohorts showed near-complete DCX ablation.
• NeuN (Neuronal Nuclei): A definitive marker of mature, differentiated post-mitotic neurons. Co-localization of BrdU with NeuN via multi-channel confocal fluorescence established that surviving newborn cells in non-irradiated mice had fully committed to a neuronal phenotype, while the baseline mature NeuN population remained structurally unharmed by the targeted irradiation.

This rigorous histological confirmation ensured that the experimental cohorts represented a clear biological dichotomy: mice with functional, antidepressant-responsive adult hippocampal neurogenesis versus mice devoid of neurogenic capacity, operating within a structurally intact and functionally responsive mature brain circuit.

5. Behavioral Assays and Phenotyping: The Novelty-Suppressed Feeding Paradigm

Evaluating antidepressant-like efficacy in animal models requires behavioral assays sensitive to chronic, rather than acute, pharmacological treatment. Traditional tests, such as the forced swim test or the tail suspension test, rapidly respond to acute, single-dose drug administration, making them unsuitable for interrogating the delayed cellular maturation mechanisms that characterize clinical response. Hen and Santarelli therefore employed the Novelty-Suppressed Feeding (NSF) paradigm as their primary behavioral assay.

5.1 Principles and Validation of the Novelty-Suppressed Feeding (NSF) Test

The Novelty-Suppressed Feeding (NSF) paradigm is an ethologically grounded behavioral assay designed around hyponeophagia—the innate fear-induced suppression of feeding in a novel, potentially threatening environment. The operational apparatus consists of an open, brightly illuminated arena (typically 40 x 40 cm or 50 x 50 cm) with a clean white floor, completely lacking protective perimeter walls or nesting materials. A single, appetizing food pellet is secured to a white platform positioned precisely in the center of the brightly lit open arena.

Prior to behavioral testing, mice are subjected to a moderate 24-hour food deprivation protocol, generating a strong, competing metabolic drive to forage and feed. When the animal is introduced into the corner of the open arena, it faces a profound emotional conflict: the homeostatic metabolic drive to run to the center and consume the food pellet directly opposes the innate fear of exposing itself to an illuminated, open, novel territory where predation risk is perceived as maximal. The operational dependent variable recorded by the investigator is the latency to feed—defined as the precise duration of time (in seconds) that elapses before the animal approaches the center pellet, positions itself on its haunches, and begins actively chewing the food.

The cardinal scientific strength of the NSF assay is its unique pharmacological sensitivity profile. Unlike the forced swim or tail suspension paradigms, the NSF test is totally unresponsive to acute (single-dose) or sub-chronic (5-day) antidepressant administration. Acute administration of SSRIs or tricyclics fails to reduce the prolonged latency to feed; in some instances, acute SSRI exposure paradoxically elevates latency due to transient anxiogenic elevations of extracellular serotonin. Only sustained, chronic administration (spanning 21 to 28 consecutive days) reliably produces a statistically robust, highly reproducible reduction in latency to feed. This makes the NSF test uniquely suited for studying the delayed therapeutic actions of antidepressants and their alignment with cellular neurogenic dynamics.

5.2 Appetitive Controls and Home-Cage Feeding Measurements

Because the Novelty-Suppressed Feeding test relies on a food-reinforced behavioral readout, any experimental manipulation that alters metabolic hunger, peripheral energy balance, satiety signaling, or general motor locomotion could produce confounding results. An animal might exhibit a reduced latency to feed simply because it is hungrier, or an elevated latency because it suffers from pharmacologically induced nausea, anorexia, or sedative motor impairment.

To eliminate these metabolic and motor confounders, the NSF paradigm requires an immediate, post-test feeding evaluation conducted within the familiar home-cage environment. Immediately upon completing the open-field test (either after the mouse bites the center pellet or when the maximum cut-off latency of 10–12 minutes is reached), the mouse is removed from the novel arena and transferred directly back to its familiar home cage containing pre-weighed food pellets. The animal is permitted to feed uninterrupted for a defined duration (typically 5 to 10 minutes), after which the consumed food mass is measured with milligram precision.

In Hen’s experiments, chronic administration of fluoxetine or imipramine, as well as the application of targeted cranial X-irradiation, produced no significant differences in home-cage food consumption among any of the experimental cohorts. All animal groups consumed equivalent masses of chow per gram of body weight during the post-test home-cage period, confirming that the hunger drive elicited by the 24-hour fast remained uniform across groups. Furthermore, automated video-tracking systems confirmed that all cohorts exhibited equivalent movement velocities and total distance traversed in the open field, confirming that variations in NSF latency were not artifacts of altered metabolic hunger or locomotor performance.

5.3 Chronic Unpredictable Stress (CUS) Assays in Hen’s Studies

To evaluate whether neurogenesis is required not only for baseline pharmacological effects, but also for rescuing mood-related deficits provoked by chronic environmental adversity, Hen incorporated the Chronic Unpredictable Stress (CUS) model. In this paradigm, mice are subjected to a randomized, continuously shifting sequence of mild psychosocial stressors over an extended four- to six-week duration. Stressors include damp bedding, continuous overnight illumination, 45-degree cage tilting, periodic predator odor exposure (such as 2,5-dihydro-2,4,5-trimethylthiazoline, or TMT), forced swim in ambient water, and intermittent cage overcrowding.

Chronic unpredictable stress induces a suite of behavioral and physical alterations mirroring key clinical features of major depression:

• Coat State Degradation: Prolonged stress diminishes spontaneous physical maintenance and self-grooming behavior, causing progressive physical degradation and unkemptness of the rodent’s fur coat. This state provides an objective, longitudinal measure of affective deterioration.
• Splash Test Grooming Latency: In this assay, a high-viscosity, 10% sucrose solution is sprayed onto the dorsal coat of the mouse. In non-stressed animals, the presence of this sticky solution reliably triggers immediate, robust, stereotypical grooming behavior. In stressed animals, the latency to initiate grooming is markedly prolonged, and total grooming duration is reduced, reflecting motivational deficits and anhedonia-like apathy.

In Hen’s experimental framework, chronic antidepressant treatment successfully rescued stress-induced behavioral deficits, restoring normal coat state and normalized splash test grooming latencies in sham-irradiated control mice. However, in mice whose hippocampal neurogenesis had been ablated via focal irradiation, chronic antidepressant treatment failed to reverse these stress-induced phenotypes. This critical finding proved that adult-born neurons are not merely involved in baseline pharmacological anxiety modulation, but are essential for reversing sustained, stress-induced behavioral despair.

6. Experimental Findings: The Uncoupling of Antidepressant Action Post-Ablation

The behavioral and histological results of the 2003 Santarelli and Hen study provided definitive empirical evidence regarding the biological necessity of adult neurogenesis. By comparing sham-irradiated and hippocampal-irradiated cohorts across diverse genetic backgrounds, the experiment definitively uncoupled monoamine elevation from behavioral recovery.

6.1 Behavioral Responses in Sham-Irradiated Control Cohorts

In the control cohorts receiving sham irradiation (which underwent identical anesthesia, stereotaxic immobilization, and lead placement, but zero X-ray exposure), chronic administration of both fluoxetine and imipramine elicited pronounced therapeutic effects across all behavioral metrics. In the Novelty-Suppressed Feeding assay, sham-irradiated 129SvEv and C57BL/6 mice treated with chronic vehicle control exhibited prolonged latencies to feed, typically hovering between 350 and 500 seconds, reflecting normal hyponeophagia.

When treated for 28 consecutive days with fluoxetine or imipramine, sham-irradiated mice showed a dramatic, statistically significant reduction in latency to approach and consume the central food pellet, with latencies decreasing to approximately 150 to 200 seconds. This pronounced behavioral shift reflected a marked reduction in anxiety-like conflict and behavioral inhibition, directly matching the classical pharmacological profile of sustained antidepressant therapy. Identical beneficial responses were documented in the splash test and coat state metrics in cohorts subjected to the chronic unpredictable stress regimen.

Parallel quantitative stereological immunohistochemistry confirmed that this behavioral improvement was accompanied by a pronounced increase in adult neurogenesis within the subgranular zone. Sham mice receiving chronic fluoxetine or imipramine showed a 2- to 2.5-fold increase in the number of BrdU-positive and DCX-positive cells throughout the dentate gyrus relative to vehicle-treated controls. Crucially, acute pharmacological exposure (1 to 5 days) neither elevated BrdU incorporation nor reduced latency to feed in the NSF paradigm. The pharmacological efficacy in sham animals exhibited an exact temporal and structural correspondence with the stimulation and maturation of new hippocampal granule neurons.

6.2 The Abolition of Therapeutic Action in Irradiated Mice

The definitive breakthrough emerged from the hippocampal-irradiated cohorts. When mice subjected to targeted focal X-irradiation were treated with chronic fluoxetine or imipramine for 28 consecutive days, the behavioral actions of both drugs were completely eradicated. In the NSF test, irradiated mice receiving chronic fluoxetine or imipramine displayed prolonged latencies to feed that were statistically indistinguishable from irradiated or sham mice treated with vehicle.

The selective serotonin reuptake inhibitor and the tricyclic antidepressant had completely lost their capacity to reduce anxiety-like conflict in the novelty-suppressed feeding test. Despite 28 days of continuous, confirmed systemic drug exposure, the animals behaved as if they had received no therapeutic intervention whatsoever. In the chronic unpredictable stress assays, irradiated mice treated with fluoxetine showed no recovery in coat score quality and retained pathologically prolonged grooming latencies in the splash test.

This experimental uncoupling was definitive. In the absence of adult hippocampal neurogenesis, the pharmacological blockade of serotonin and norepinephrine transporters was rendered clinically inert in these behavioral domains. The experimental result provided direct, unambiguous loss-of-function evidence: adult neurogenesis was not an incidental downstream byproduct of monoaminergic medication, but the mandatory biological mechanism mediating behavioral recovery.

6.3 Strain-Specific Variances: C57BL/6 versus 129SvEv Responses

The comparative utilization of both C57BL/6 and 129SvEv mouse strains yielded valuable insights into genetic modulation and neurogenic dynamics. Baseline cellular proliferation differed significantly between the two strains, with non-stressed C57BL/6 mice exhibiting substantially higher baseline rates of adult neurogenesis and lower baseline anxiety metrics in the NSF paradigm than the 129SvEv cohort.

Furthermore, pharmacological sensitivities showed strain-dependent variations in untreated baseline states. 129SvEv mice exhibited marked behavioral responsiveness to the selective serotonin reuptake inhibitor fluoxetine, displaying a large dynamic range of latency reduction in the NSF paradigm. C57BL/6 mice, while also responding to fluoxetine, exhibited particularly pronounced responses to the dual reuptake inhibitor imipramine. These differential response profiles reflect baseline strain differences in central serotonergic and noradrenergic receptor distributions and tone.

Crucially, despite these underlying genetic, neurochemical, and behavioral differences, targeted hippocampal X-irradiation completely abolished the behavioral efficacy of both fluoxetine and imipramine in *both* mouse strains. The absolute requirement for intact neurogenesis transcended the divergent genetic backgrounds. Whether an animal possessed high or low baseline anxiety, or whether its neurochemistry was biased toward serotonergic or noradrenergic tone, the elimination of adult neurogenesis uniformly blocked behavioral recovery. This confirmed that Hen’s findings reflected a generalizable, conserved mammalian biological mechanism.

7. Molecular Signaling Cascades Linking Monoamines to Proliferation

The behavioral findings of the 2003 experiment compelled neuroscientists to map the downstream molecular signaling cascades through which chronic elevation of extracellular monoamines drives the mitotic proliferation, differentiation, and survival of adult-born neural progenitors within the subgranular niche.

7.1 Serotonin 1A Receptor (5-HT1A) Activation in the Dentate Gyrus

The initiation of antidepressant-induced neurogenesis depends heavily on the activation of specific monoamine receptor subtypes. René Hen’s laboratory had laid the groundwork for this line of inquiry through extensive work with serotonin 1A receptor (5-HT1A) knockout mouse models. The 5-HT1A receptor is a G-protein-coupled receptor that operates in two distinct anatomical compartments: as a somatodendritic autoreceptor on serotonergic neurons in the dorsal and median raphe nuclei, and as a post-synaptic heteroreceptor on mature pyramidal and granule cells throughout the limbic system, including the dentate gyrus.

When an SSRI is acutely administered, the initial surge of extracellular serotonin activates raphe somatodendritic 5-HT1A autoreceptors, triggering Gi/o-protein coupling that inhibits adenylyl cyclase, opens G-protein-coupled inwardly rectifying potassium channels (GIRKs), hyperpolarizes the neuron, and sharply suppresses serotonergic firing. This negative feedback loop initially dampens central serotonin release. However, under continuous chronic SSRI administration, these somatodendritic 5-HT1A autoreceptors undergo sustained agonist-induced desensitization and internalization. This down-regulation relieves the self-inhibitory brake, allowing raphe neurons to resume normal and enhanced firing, flooding post-synaptic limbic targets with serotonin.

Within the dentate gyrus, this elevated serotonergic tone activates post-synaptic 5-HT1A heteroreceptors expressed on mature granule cells and localized interneurons, as well as on neural stem cells within the subgranular niche. Post-synaptic 5-HT1A receptor activation couples to intracellular mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) pathways. Phosphorylation of ERK stimulates transit-amplifying Type-2 progenitor cells, driving their entry from quiescent G0 states into active G1 mitotic cycles. Hen demonstrated that in 5-HT1A knockout mice, fluoxetine completely fails to stimulate hippocampal neurogenesis, confirming that this specific serotonergic receptor subtype is the essential receptor gateway transducing extracellular 5-HT elevation into intracellular mitogenic signals.

7.2 Intracellular Cascades: cAMP, PKA, and CREB Phosphorylation

Beyond the MAPK/ERK pathway, chronic monoamine elevation triggers the sustained activation of the cyclic adenosine monophosphate (cAMP) second-messenger cascade. Chronic activation of Gs-coupled monoaminergic receptors (such as the 5-HT4, 5-HT7, and beta-adrenergic receptor subtypes) stimulates the integral membrane enzyme adenylyl cyclase, prompting continuous synthesis of intracellular cAMP from cytosolic adenosine triphosphate (ATP).

Elevated intracellular cAMP binds to the regulatory subunits of protein kinase A (PKA), releasing its active catalytic subunits. These catalytic subunits translocate into the cell nucleus, where they phosphorylate the transcription factor cAMP-response element-binding protein (CREB) at its critical regulatory serine-133 residue. Phosphorylation of CREB permits the recruitment of the transcriptional coactivator CREB-binding protein (CBP), assembling an active transcriptional initiation complex on specific cAMP response elements (CRE) in promoter regions of target genes.

This sustained CREB activation operates as a master transcriptional switch within the neurogenic niche. Phospho-CREB drives the transcription of critical pro-survival and pro-proliferative genes, including the anti-apoptotic regulator Bcl-2, the cell-cycle promoter Cyclin D1, and neurotrophic growth factors. Pre-clinical studies utilizing viral vectors to express constitutively active forms of CREB directly within the dentate gyrus showed that autonomous CREB activation is sufficient to mimic both the neurogenic and behavioral anxiolytic actions of chronic antidepressants, establishing the cAMP-PKA-CREB cascade as a primary intracellular conduit of structural neuroplasticity.

7.3 Neurotrophin Dynamics: BDNF-TrkB Signaling Transduction

A primary transcriptional target of CREB activation is the gene encoding brain-derived neurotrophic factor (BDNF). Following chronic antidepressant administration, BDNF mRNA and protein levels rise substantially throughout the hippocampal formation, particularly within the mossy fiber axons of dentate granule cells and their target CA3 pyramidal dendrites. The newly synthesized BDNF is secreted via activity-dependent exocytosis into the surrounding subgranular extracellular matrix, establishing an autocrine and paracrine signaling environment.

Extracellular BDNF binds with high affinity to the tropomyosin receptor kinase B (TrkB) receptor, which is expressed on both proliferating progenitor cells and differentiating neuroblasts. Ligand binding induces TrkB receptor homodimerization and rapid trans-autophosphorylation of specific intracellular tyrosine residues within its kinase domain. This autophosphorylation recruits scaffolding adapter proteins, triggering two dominant intracellular signaling cascades:

• The Phosphoinositide 3-Kinase (PI3K)/Akt Pathway: Activation of PI3K converts PIP2 into PIP3, recruiting the serine/threonine kinase Akt to the plasma membrane. Activated Akt directly phosphorylates and inactivates glycogen synthase kinase 3-beta (GSK3β) and the pro-apoptotic protein BAD, promoting the survival and inhibiting the programmed cell death of newly born immature neurons.
• The Phospholipase C-gamma (PLCγ) Cascade: PLCγ generates diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), mobilizing intracellular calcium stores from the endoplasmic reticulum and activating calcium/calmodulin-dependent protein kinases (CaMKs), which amplify CREB phosphorylation in an ongoing positive feedback loop.

In parallel with BDNF, chronic antidepressant exposure upregulates vascular endothelial growth factor (VEGF) and its high-affinity receptor Flk-1 within the subgranular zone. This induces local endothelial microvascular proliferation, generating dense capillary networks that provide oxygen, nutrients, and circulating systemic growth factors that sustain the expanding neural stem cell niche.

8. Structural and Functional Integration of Newborn Granule Neurons

The biological requirement for a multi-week antidepressant regimen stems directly from the prolonged, complex developmental trajectory through which newly born neural progenitor cells transition from proliferating stem cells into functionally mature, synaptically integrated dentate granule neurons.

8.1 Developmental Trajectory: From Intermediate Progenitor to Mature Neuron

The progression of an adult-born cell from its initial mitotic birth to complete functional maturity spans a developmental window of six to eight weeks in rodents, characterized by distinct morphological, transcriptional, and physiological transitions:

• Week 1 (Proliferation and Initial Lineage Commitment): Multipotent Type-1 radial glia-like progenitors divide to produce actively cycling Type-2 intermediate progenitors, which quickly transition into post-mitotic, DCX-positive Type-3 neuroblasts. These cells migrate a short distance from the subgranular zone into the inner border of the granule cell layer.
• Week 2 (Polarization and Process Outgrowth): Surviving immature neurons extend a single apical dendritic process perpendicular to the hilar border, projecting outward through the granule cell layer into the molecular layer. Concurrently, they project a thin, unmyelinated axon—the mossy fiber—along the polymorphic hilus toward the hippocampal CA3 pyramidal cell field.
• Weeks 3 to 4 (Synaptogenesis and Dendritic Branching): The apical dendritic arbor branches extensively throughout the inner, middle, and outer molecular layers, forming initial immature dendritic spines that receive excitatory glutamatergic synaptic inputs from the lateral and medial entorhinal cortex (the perforant path). Axonal mossy fiber boutons form preliminary synaptic connections with CA3 pyramidal cell dendrites and local inhibitory interneurons.
• Weeks 6 to 8 (Functional Consolidation and Full Maturity): The newborn granule cell down-regulates immature markers like DCX and Calretinin, up-regulates mature neuronal markers including Calbindin and NeuN, and stabilizes its spine density. The adult-born neuron becomes morphologically and physiologically indistinguishable from developmentally generated mature dentate granule neurons.

This biological timeline cleanly explains the latency paradox of antidepressant therapy. If therapeutic efficacy depends upon the functional incorporation of these cells, clinical recovery cannot manifest until the newly generated cohort completes this developmental program and forms active, functional connections within the hippocampal trisynaptic circuit.

8.2 The Critical Window of Heightened Synaptic Plasticity

During their developmental maturation—specifically between three and six weeks post-mitosis—young adult-born dentate granule neurons exhibit physiological properties that distinguish them from mature, developmentally generated granule cells. This stage represents a “critical window” during which newborn cells exert an outsized computational influence on hippocampal network dynamics.

Immature granule cells during this period possess a significantly lower activation threshold and an enhanced capacity for long-term potentiation (LTP). While mature granule neurons are under powerful tonic inhibition from local GABAergic interneurons (such as parvalbumin-positive basket cells) and require intense, high-frequency tetanic stimulation to induce synaptic potentiation, 4-week-old newborn neurons exhibit a much lower induction threshold and a higher maximal LTP amplitude under identical stimulation protocols.

This heightened synaptic plasticity is driven largely by delayed physiological shifts in chloride homeostasis. In very young immature neurons, high intracellular chloride concentrations—maintained by the Na⁺-K⁺-2Cl^– cotransporter NKCC1—mean that the binding of gamma-aminobutyric acid (GABA) to ionotropic GABA_A receptors causes chloride efflux, resulting in membrane depolarization rather than classic hyperpolarization. Only as the neuron reaches 4 to 6 weeks of age does the potassium-chloride cotransporter KCC2 become fully expressed, extruding intracellular chloride and shifting GABAergic transmission to its canonical inhibitory hyperpolarizing role. During this developmental transition, young neurons experience reduced synaptic inhibition, allowing them to remain excitable and highly plastic in response to environmental and behavioral stimuli.

8.3 Functional Circuit Integration and Mossy Fiber Connectivity

As these young neurons mature, their axonal mossy fibers form expansive, multi-site synaptic complexes within the stratum lucidum of the CA3 subfield. A single mossy fiber axon from an adult-born neuron possesses multiple distinct terminal specializations:

• Large Mossy Fiber Boutons: Massive, complex presynaptic terminals (3 to 6 micrometers in diameter) that form multiple active zones with thorny excrescences on the apical dendrites of CA3 pyramidal neurons, providing powerful, dynamic excitatory drive.
• Filopodial Extensions: Fine, finger-like filopodial projections emanating from the perimeter of large boutons that selectively target local, feedforward inhibitory interneurons, such as stratum lucidum interneurons and parvalbumin-positive basket cells.
• Small En Passant Boutons: Smaller presynaptic terminals that synapse onto inhibitory interneurons and mossy cells throughout the polymorphic hilus.

Through this tripartite anatomical arrangement, adult-born granule neurons recruit local feedforward inhibitory networks, effectively resetting hippocampal outflow. By activating inhibitory interneurons within the CA3 network, newborn neurons dampen aberrant, hyperactive firing across the CA3 recurrent auto-associative network. This circuit configuration provides an anatomical “dentate gate,” preventing widespread, synchronized epileptiform activity and runaway excitotoxic signaling, while permitting sparse, highly specific contextual representations to propagate successfully through the hippocampal trisynaptic circuit.

9. The Stress-Neurogenesis Interaction and HPA Axis Regulation

The clinical manifestations of major depressive disorder are tightly linked to neuroendocrine dysregulation, primarily characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. Hen’s subsequent research revealed that adult-born granule neurons play an active regulatory role in dampening systemic stress responses.

9.1 Glucocorticoid Receptor Activation and Dendritic Retraction

The hippocampus contains the highest concentration of corticosteroid receptors in the mammalian central nervous system, expressing both high-affinity mineralocorticoid receptors (MRs) and lower-affinity glucocorticoid receptors (GRs). Under baseline circadian conditions, basal levels of corticosterone predominantly saturate the high-affinity MRs. During sustained, chronic stress, sustained systemic glucocorticoid surges saturate low-affinity GRs throughout the dentate gyrus and CA subfields.

Prolonged GR saturation triggers adverse molecular cascades within the subgranular niche. Elevated glucocorticoids impair the transcription of basic helix-loop-helix neurogenic factors (such as NeuroD1 and Mash1), directly arresting Type-2 progenitor cells in the G1 phase of the cell cycle. Concurrently, glucocorticoid excess downregulates astrocytic glutamate transporters (GLT-1 and GLAST), allowing extracellular glutamate to accumulate to excitotoxic concentrations, which accelerates apoptotic pruning of newly generated DCX-positive neuroblasts. In mature CA3 pyramidal neurons and mature dentate granule cells, prolonged GR activation induces progressive debranching of apical dendrites, loss of dendritic spines, and a marked reduction in total hippocampal synaptic connectivity.

9.2 Adult-Born Neurons as Dampeners of the Hypothalamic-Pituitary-Adrenal Axis

While stress suppresses neurogenesis, Hen and other investigators—notably Jason Snyder and Heather Cameron—discovered that adult-born neurons exert essential reciprocal negative feedback control over the HPA axis itself. In a homeostatic neuroendocrine loop, the activation of the HPA axis triggers the release of Corticotropin-Releasing Factor (CRF) from the paraventricular nucleus (PVN) of the hypothalamus, stimulating the anterior pituitary to secrete Adrenocorticotropic Hormone (ACTH), which drives the adrenal cortex to synthesize and release glucocorticoids into systemic circulation.

Under normal conditions, systemic glucocorticoids cross the blood-brain barrier and bind to hippocampal corticosteroid receptors, activating an inhibitory projection that terminates back upon the hypothalamic PVN, shutting off further CRF secretion and terminating the stress response. Hen and his colleagues demonstrated that mice depleted of adult hippocampal neurogenesis (via targeted irradiation or pharmacogenetic ablation) display a profound impairment in this negative feedback loop. When exposed to an acute psychological stressor (such as restraint stress), neurogenesis-deficient animals exhibit normative initial peaks of ACTH and corticosterone, but their post-stress hormonal concentrations remain pathologically elevated for hours. The termination phase of the neuroendocrine stress response fails completely.

Adult-born granule cells restore this critical negative feedback by recruiting the feedforward inhibitory networks that project to the PVN. By stimulating local interneurons in CA3 and the subiculum, young granule cells drive downstream GABAergic projections to the hypothalamus, silencing CRF neurosecretory cells and terminating the hormonal cascade. Antidepressant-mediated stimulation of neurogenesis directly repairs this neuroendocrine brake, restoring normative corticosterone recovery curves and shielding the central nervous system from chronic, systemic glucocorticoid toxicity.

9.3 Contextual Discrimination and Stress Generalization

A core cognitive and emotional deficit shared by major depressive disorder and post-traumatic stress disorder (PTSD) is stress overgeneralization—the maladaptive failure to distinguish safe environmental contexts from previously experienced threatening or traumatic situations. A patient overgeneralizes fear when benign, ambiguous environmental cues trigger the same autonomic and emotional panic elicited by the original trauma.

Computational and behavioral neuroscience has firmly established that the dentate gyrus is the primary archicortical substrate mediating pattern separation: the computational transformation of overlapping, highly similar sensory inputs into completely distinct, non-overlapping physiological circuit representations. Adult-born granule neurons, through their enhanced synaptic plasticity and unique feedforward connectivity, are uniquely specialized to execute fine pattern separation. When young adult-born neurons are present, the dentate gyrus successfully distinguishes between Context A (a previously shock-paired fearful cage) and Context B (a novel, safe cage sharing overlapping lighting, dimensional, and olfactory features).

In mice where adult neurogenesis has been ablated, pattern separation fails completely. The animals exhibit generalized freezing behavior across all contexts, treating the safe, novel arena as identical to the threatening environment. Hen demonstrated that chronic antidepressant administration rescues pattern separation deficits by expanding the pool of plastic, 4- to 6-week-old young granule neurons. This expansion enables the hippocampal network to resolve ambiguous environmental inputs, preventing maladaptive fear generalization and supporting cognitive-affective flexibility.

10. Critical Caveats, Conflicting Findings, and Independent Pathways

Despite the clarity of Hen’s 2003 findings, the adult neurogenesis hypothesis of depression encountered immediate debate within the neuroscientific community. Diverse behavioral assays, alternative ablation methods, and independent, non-neurogenic pathways of neuroplasticity highlighted the nuanced complexity of affective neuroscience.

10.1 Behavioral Paradigm Dependencies: Beyond the NSF Test

The most immediate challenge to the universality of Hen’s findings arose from investigations utilizing traditional behavioral despair paradigms, such as the Forced Swim Test (FST) and the Tail Suspension Test (TST). In classic studies conducted by Justin Holick and colleagues, mice subjected to cranial X-irradiation or systemic anti-mitotic drug treatments still exhibited significant reductions in immobility time following antidepressant administration. The therapeutic-like response in the FST and TST persisted unabated despite the near-total ablation of adult hippocampal neurogenesis.

These findings highlighted critical operational distinctions among rodent behavioral assays. The Forced Swim Test and Tail Suspension Test evaluate acute stress coping strategies and passive versus active behavioral transitions under inescapable physical threat; they do not measure complex, conflict-based emotional decision-making, nor do they mirror the delayed therapeutic timeline of human clinical treatment. In contrast, paradigms such as the Novelty-Suppressed Feeding test, the splash test following chronic unpredictable stress, and contextual pattern separation assays interrogate persistent, conflict-driven affective processing and require multi-week chronic pharmacological administration. The scientific community recognized that adult neurogenesis is not a blanket mediator of every rodent behavioral readout, but is specifically required for complex anxiolytic tasks, emotional conflict resolution, and the reversal of sustained, stress-induced behavioral despair.

10.2 Potential Methodological Side Effects of Cranial Irradiation

A second major methodological critique focused on the use of focal ionizing radiation. Skeptics argued that high-energy X-ray photons might induce sub-threshold, non-specific biological side effects, including:

• Radiation-Induced Microgliosis: Ionizing radiation can activate resident microglial populations, inducing a chronic, localized neuroinflammatory response characterized by elevated secretion of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α), both of which suppress neuroplasticity and promote depressive phenotypes.
• Microvascular Disruption: High-dose irradiation can damage endothelial cells, altering blood-brain barrier permeability and compromising the transport of circulating neurotrophic ligands.
• Extraneurogenic Parenchymal Effects: Potential sub-cellular damage to mature, non-cycling post-mitotic neurons and surrounding astroglial architecture.

To definitively address these concerns, independent research groups developed non-radiological, genetic ablation models. Researchers constructed transgenic mouse lines utilizing the herpes simplex virus thymidine kinase (HSV-TK) gene driven by neural stem cell-specific promoters, such as the Glial Fibrillary Acidic Protein (GFAP-TK) promoter or the Nestin promoter (Nestin-TK). In these transgenic mice, administration of the antiviral prodrug ganciclovir selectively arrests DNA replication and induces apoptosis exclusively in proliferating GFAP- or Nestin-expressing stem cells, achieving profound neurogenic ablation without ionizing radiation. Studies using GFAP-TK and inducible Diphtheria Toxin A (DTA) genetic ablation models completely replicated René Hen’s original findings: chronic antidepressants failed to reduce NSF latencies in genetically ablated mice. This validation confirmed that the loss of antidepressant efficacy was caused specifically by the depletion of adult-born neurons, not by collateral radiation artifacts.

10.3 Non-Neurogenic Mechanisms of Antidepressant Pharmacodynamics

While the necessity of adult neurogenesis was established for specific hippocampal-dependent behaviors, extensive evidence confirmed that antidepressants simultaneously recruit multiple parallel, non-neurogenic pathways of structural plasticity throughout the central nervous system:

• Cortical Spinogenesis: In the medial prefrontal cortex (mPFC), chronic antidepressant treatment enhances the density and maturation of dendritic spines on mature layer V pyramidal neurons, stimulating synaptogenesis independently of cellular division.
• Epigenetic Remodeling: Antidepressants alter chromatin architecture by inhibiting histone deacetylases (HDACs) and modulating DNA methyltransferase (DNMT) activity, driving transcriptional upregulation of neuroprotective networks in mature, post-mitotic neuronal populations.
• Glial and Astroglial Adaptations: Chronic SSRI administration stimulates astrocytic production of neurotrophic factors and strengthens the gap-junction connectivity of mature astroglial networks, improving parenchymal metabolic support and glutamate reuptake kinetics.

The multi-faceted nature of antidepressant action is highlighted by rapid-acting psychotropic agents like the NMDA receptor antagonist ketamine. Ketamine elicits profound, robust antidepressant responses in humans and animal models within two to four hours of administration—a timeline that excludes intermediate progenitor mitosis and multi-week neuronal maturation. Ketamine operates through rapid, burst-like release of BDNF, transient activation of the mechanistic target of rapamycin complex 1 (mTORC1) cascade, and rapid insertion of AMPA receptors into pre-existing synaptic junctions throughout the prefrontal cortex and CA1 hippocampus. Thus, while classic monoaminergic antidepressants depend upon adult neurogenesis for sustained, long-term emotional recalibration, independent non-neurogenic mechanisms can drive rapid synaptic remodeling.

11. Translational Relevance: Human Adult Neurogenesis and Depressive Pathology

Establishing a neurobiological mechanism in rodent models holds clinical relevance only if the underlying biological processes are conserved in the human brain. The translational validation of Hen’s paradigm required demonstrating that adult neurogenesis occurs in adult humans and is pathologically disrupted in clinical depression.

11.1 The Methodological Debate Surrounding Adult Neurogenesis in Humans

The empirical demonstration of adult neurogenesis in the human brain has been technically challenging, constrained by post-mortem autolysis, variable tissue fixation protocols, and the ethical impossibility of administering in vivo cell-proliferation tracers like BrdU to healthy human volunteers. Early clinical validation emerged in 1998 through a landmark study by Peter Eriksson, Fred Gage, and colleagues, who examined post-mortem brain tissue from terminally ill cancer patients who had received systemic BrdU infusions for diagnostic tumor-tracking purposes. Confocal immunohistochemistry revealed BrdU-labeled cells co-expressing the mature neuronal marker NeuN within the human dentate gyrus, establishing proof-of-principle that the adult human subgranular zone retains neurogenic capacity.

A methodological advance occurred through retrospective carbon-14 (¹⁴C) dating pioneered by Kirsty Spalding, Jonas Frisén, and their team at the Karolinska Institute. During the Cold War era of above-ground nuclear weapons testing (1955–1963), atmospheric concentrations of ¹⁴C elevated sharply and subsequently declined at a well-characterized rate following the Limited Nuclear Test Ban Treaty. As cells undergo mitotic division, they incorporate atmospheric ¹⁴C into their genomic DNA in concentrations reflecting ambient levels at the time of mitosis. By extracting genomic DNA from purified neuronal nuclei within post-mortem human dentate gyri and measuring ¹⁴C ratios via accelerator mass spectrometry, Spalding and Frisén established that a substantial fraction of human dentate granule neurons undergoes continuous turnover throughout adulthood. They calculated that approximately 700 new neurons are added to the human dentate gyrus per day, corresponding to an annual turnover rate of roughly 1.75%—a magnitude fully sufficient to exert continuous computational and affective influence throughout human life.

Despite these findings, the field encountered renewed controversy in 2018 when a study by Sorrells and colleagues asserted that human hippocampal neurogenesis drops to undetectable levels during early childhood and is virtually absent in adults. However, this claim was quickly refuted by comprehensive studies directed by Maura Boldrini at Columbia University and Maria Llorens-Martín at the Universidad Autónoma de Madrid. Utilizing tightly controlled tissue-preservation techniques that eliminated post-mortem fixation artifacts, Boldrini and Llorens-Martín confirmed the persistent, lifelong presence of thousands of DCX-positive immature neurons, Sox2-positive neural progenitors, and PCNA-labeled cycling cells in neurologically healthy human individuals across the lifespan, from young adulthood into the eighth and ninth decades of life.

11.2 Hippocampal Volume and Pathological Manifestations in Human MDD

The clinical manifestations of major depressive disorder in humans closely mirror the structural and cellular phenotypes predicted by Hen’s neurogenic model. Decades of clinical neuroimaging have established that untreated, recurrent MDD is accompanied by measurable, bilateral reductions in hippocampal volume. Longitudinal, high-resolution 7-Tesla MRI studies confirmed that this volumetric shrinkage is localized to the dentate gyrus and the CA3/subicular subfields.

Crucially, longitudinal neuroimaging demonstrated that this volumetric atrophy is both preventable and reversible. Depressed patients who receive sustained, uninterrupted treatment with classic monoaminergic antidepressants—and who achieve sustained clinical remission—demonstrate progressive restoration of hippocampal volume over months and years of follow-up. In contrast, patients who experience chronic, untreated illness or frequent relapses exhibit progressive volumetric reductions that correlate with persistent executive, mnemonic, and emotional deficits.

Post-mortem stereological analyses of clinical cohorts conducted by Boldrini and colleagues provided cellular validation for these imaging findings. Unmedicated depressed individuals who died by suicide exhibited a marked reduction in the volume of the dentate gyrus, driven by a depleted pool of neural progenitors and DCX-positive immature neurons relative to matched, healthy control subjects. In stark contrast, depressed patients who were actively receiving chronic antidepressant pharmacotherapy at the time of death displayed normalized numbers of neural progenitor cells and an expanded population of immature granule neurons. These human post-mortem findings provided clinical validation of René Hen’s pre-clinical work, demonstrating that antidepressants directly stimulate structural neurogenesis in the human brain.

11.3 Implications for Treatment Resistance and Novel Clinical Diagnostics

The confirmation of the neurogenesis hypothesis provides a mechanistic framework for understanding treatment-resistant depression (TRD). A significant proportion of depressed patients—historically estimated between 30% and 40%—fail to achieve clinical remission despite multiple adequate trials of first- and second-line monoaminergic antidepressants. Within a structural neuroplasticity framework, treatment resistance can be re-conceptualized as a failure of the neurogenic niche to respond to monoaminergic signaling.

In patients with TRD, sustained neuroinflammation (elevated peripheral and central IL-6, TNF-α, and microglial activation), persistent HPA axis hyperactivity, or genetic variations in neurotrophin pathways (such as the BDNF Val66Met polymorphism) can render the subgranular zone refractory to monoaminergic stimulation. In such individuals, elevating synaptic serotonin or norepinephrine fails to stimulate progenitor mitosis, leaving the dysfunctional, stress-atrophied hippocampal circuit intact. This failure explains why simply switching an unresponsive patient from one SSRI to an alternative monoamine-reuptake inhibitor often produces minimal therapeutic benefit.

These insights have driven efforts to develop non-invasive, in vivo clinical biomarkers of neurogenesis. Emerging neuroimaging technologies—including magnetic resonance spectroscopy (MRS) targeting a specific 1.28-ppm metabolic biomarker unique to neural progenitor cells, alongside the development of radiolabeled positron emission tomography (PET) tracers targeting neurogenic markers—aim to provide clinicians with real-time diagnostic readouts of a patient’s hippocampal neurogenic capacity. Such diagnostic tools could soon allow physicians to identify patients with neurogenic failure and stratify them toward non-monoaminergic therapeutic interventions designed to bypass defective stem-cell niches.

12. The Legacy and Evolution of Hen’s Paradigm in Modern Psychiatry

René Hen’s 2003 breakthrough transformed psychiatric neuroscience, shifting the field from static neurochemical paradigms to a dynamic neurodevelopmental framework. The methodological and conceptual foundation laid by Hen continues to steer modern therapeutic discovery and advanced circuit-level interrogation.

12.1 Next-Generation Circuit Interrogations: Optogenetics and Chemogenetics

In the decades following the 2003 experiment, the neuroscience community moved beyond non-specific ablation models to cell-type-specific, temporally precise circuit manipulation. The advent of optogenetics and chemogenetics allowed researchers to evaluate the function of adult-born neurons with millisecond temporal resolution and single-cell genetic specificity.

Utilizing transgenic driver mouse lines (such as Ascl1-CreERT2 or Nestin-CreERT2) combined with targeted retroviral or adeno-associated viral (AAV) vectors, researchers can selectively express light-sensitive microbial opsins—such as Channelrhodopsin-2 (ChR2) for excitation, or Halorhodopsin (NpHR) and Archaerhodopsin (Arch) for optical silencing—exclusively in newly generated dentate granule neurons born during a defined temporal window. Seminal follow-up studies led by René Hen, Amar Sahay, and Mazen Kheirbek utilized implanted intracranial fiber optics to directly stimulate or silence young adult-born neurons during active behavioral tasks.

These optogenetic studies demonstrated that selectively illuminating and activating 4-week-old young adult-born granule neurons during behavioral testing directly reduces anxiety-like conflict in the Novelty-Suppressed Feeding paradigm, mimicking the effects of chronic antidepressant exposure without requiring any pharmacological drug administration. Conversely, acute optogenetic silencing of this young cell cohort instantaneously abolished pattern separation performance and triggered behavioral arrest in ambiguous environments. Subsequent chemogenetic studies utilizing Designer Receptors Exclusively Activated by Designer Drugs (DREADDs)—such as the Gq-coupled hM3Dq receptor or the Gi-coupled hM4Di receptor activated by clozapine-N-oxide (CNO)—confirmed that sustained, reversible modulation of adult-born neuron excitability controls affective behaviors in real time. These optogenetic and chemogenetic experiments confirmed Hen’s original causal hypothesis: young adult-born neurons are not merely passive structural components, but active, dynamic circuit elements capable of directing emotional and anxiety-related behavioral states.

12.2 Discovery of Pro-Neurogenic Compounds Lacking Direct Monoaminergic Action

The realization that adult neurogenesis is a non-negotiable mediator of long-term structural and emotional recovery redirected psychiatric drug discovery toward the search for non-monoaminergic, pro-neurogenic small molecules. Rather than focusing on cell-surface monoaminergic reuptake transporters, industrial and academic drug pipelines began conducting high-throughput phenotypic screens to identify chemical compounds that directly stimulate progenitor cell mitosis, promote neuroblast survival, and accelerate synaptogenesis.

A prominent example was the discovery of the P7C3 series of neuroprotective aminopropyl carbazole compounds by Andrew Pieper and Steven McKnight. Identified via in vivo phenotypic screens in rodents, P7C3 compounds possess no binding affinity for the serotonin, norepinephrine, or dopamine transporters, nor do they activate traditional monoaminergic receptors. Instead, P7C3 enhances the enzymatic activity of nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme in the salvage pathway of nicotinamide adenine dinucleotide (NAD+) biosynthesis. By elevating intracellular NAD+ levels within newborn neural progenitors, P7C3 prevents mitochondrial outer membrane permeabilization, blocks apoptotic death in DCX-positive neuroblasts, and drives a sustained expansion of functional adult-born granule neurons. In behavioral assays, administration of P7C3 compounds elicited robust, long-term antidepressant-like and pro-cognitive actions in animals subjected to chronic stress or cranial irradiation, providing proof-of-concept that direct pro-neurogenic compounds can achieve therapeutic efficacy without acting on monoaminergic systems.

Concurrently, drug discovery programs targeted specific GPCRs and developmental pathways that stimulate the subgranular neurogenic niche:

• 5-HT4 Receptor Agonists: Agonism of the Gs-coupled 5-HT4 receptor directly stimulates intracellular adenylyl cyclase within the hippocampus, inducing rapid increases in BDNF synthesis and accelerating the morphological maturation of immature granule neurons within days rather than weeks.
• Wnt/Beta-Catenin Signaling Modulators: Small molecules that stabilize canonical Wnt signaling stimulate the asymmetric division of quiescent Type-1 radial glia, expanding intermediate progenitor populations.
• Phosphodiesterase Inhibitors (PDE4 Inhibitors): Agents such as rolipram prevent the degradation of intracellular cAMP, sustaining PKA activity and CREB phosphorylation to support the survival and circuit integration of adult-born neurons.

These diverse molecular strategies represent a shift away from classical monoaminergic reuptake inhibition toward targeted, direct structural rejuvenation of the hippocampal circuit.

12.3 Conclusion: René Hen’s Enduring Conceptual Paradigm Shift

The 2003 experiment published by René Hen, Luca Santarelli, and their colleagues represents a historic inflection point in the conceptual evolution of modern psychiatry. By demonstrating that targeted cranial X-irradiation abolished the behavioral efficacy of classic antidepressants, Hen’s team demolished the simplistic notion of depression as an acute “chemical imbalance” of monoaminergic neurotransmitters. In its place, they established a dynamic, neurodevelopmental model wherein affective health depends on the brain’s continuous capacity for structural remodeling, functional circuit integration, and lifelong cellular neurogenesis.

The implications of this paradigm shift extend far beyond the dentate gyrus. Hen’s work provided a generalizable neurobiological framework linking cellular neurodevelopment, neuroendocrine stress regulation, and affective behavior. It explained the clinical latency of psychiatric pharmacotherapies, elucidated how chronic stress physically atrophies limbic circuitry, and illuminated how downstream neurotrophic signaling restores cognitive and emotional adaptability. In bridging the conceptual chasm between molecular pharmacology and macroscopic human behavior, René Hen and his collaborators delivered an enduring insight: the adult brain retains the biological capacity to rewrite its own architecture, and this continuous regeneration is a fundamental prerequisite for emotional recovery.

References

• Altman, J. (1962). Are new neurons formed in the brains of adult mammals? Science, 135(3509), 1127–1128. https://doi.org/10.1126/science.135.3509.1127
• Boldrini, M., Fulmore, C. A., Tartt, A. N., Simeon, L. R., Pavlova, I., Poposka, V., Rosoklija, G. B., Stankov, A., Arango, V., Dwork, A. J., Hen, R., & Mann, J. J. (2018). Human adult neurogenesis persists throughout aging. Cell Stem Cell, 22(4), 589–599.e5. https://doi.org/10.1016/j.stem.2018.03.015
• Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000). Hippocampal volume reduction in major depression. The American Journal of Psychiatry, 157(1), 115–118. https://doi.org/10.1176/ajp.157.1.115
• Duman, R. S., Malberg, J., Nakagawa, S., & D’Sa, C. (2000). Neuronal plasticity and survival in mood disorders. Biological Psychiatry, 48(8), 732–739. https://doi.org/10.1016/S0006-3223(00)00935-5
• Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998). Neurogenesis in the adult human hippocampus. Nature Medicine, 4(11), 1313–1317. https://doi.org/10.1038/3305
• Gould, E., Beylin, A., Tanapat, P., Reeves, A., & Shors, T. J. (1999). Learning enhances adult neurogenesis in the hippocampal formation. Nature Neuroscience, 2(3), 260–265. https://doi.org/10.1038/6365
• Holick, K. A., Lee, D. C., Hen, R., & Dulawa, S. C. (2008). Behavioral effects of chronic fluoxetine in mice do not require adult hippocampal neurogenesis or 5-HT1A receptors. Neuropsychopharmacology, 33(2), 406–417. https://doi.org/10.1038/sj.npp.1301399
• Kheirbek, M. A., Drew, L. J., Burghardt, N. S., Costantini, D. O., Tannenholz, L., Ahmari, S. E., Zeng, H., Fenton, A. A., & Hen, R. (2013). Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron, 77(5), 955–968. https://doi.org/10.1016/j.neuron.2012.12.038
• Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience, 20(24), 9104–9110. https://doi.org/10.1523/JNEUROSCI.20-24-09104.2000
• McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience, 22, 105–122. https://doi.org/10.1146/annurev.neuro.22.1.105
• Pieper, A. A., Xie, S., Capota, E., Estill, S. J., Zhong, J., Long, J. M., Becker, G. L., Huntington, P., Goldman, S. E., Shen, C. H., Capota, M., Britt, J. K., Kotti, T., Ure, K., Brat, D. J., Williams, N. S., MacMillan, K. S., Naidoo, J., Melito, L., Hsieh, J., De Brabander, J., Ready, J. M., & McKnight, S. L. (2010). Discovery of a pro-neurogenic, neuroprotective chemical. Cell, 142(1), 39–51. https://doi.org/10.1016/j.cell.2010.06.018
• Sahay, A., Scobie, K. N., Hill, A. S., O’Carroll, C. M., Kheirbek, M. A., Burghardt, N. S., Fenton, A. A., Dranovsky, A., & Hen, R. (2011). Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature, 472(7344), 466–470. https://doi.org/10.1038/nature09817
• Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., & Hen, R. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301(5634), 805–809. https://doi.org/10.1126/science.1083328
• Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry, 57(10), 925–935. https://doi.org/10.1001/archpsyc.57.10.925
• Saxe, M. D., Battaglia, F., Wang, J. W., Malleret, G., David, D. J., Monckton, J. E., Garcia, A. D., Sofroniew, M. V., Kandel, E. R., Santarelli, L., Hen, R., & Drew, M. R. (2006). Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proceedings of the National Academy of Sciences of the United States of America, 103(46), 17501–17506. https://doi.org/10.1073/pnas.0607207103
• Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. The American Journal of Psychiatry, 122(5), 509–522. https://doi.org/10.1176/ajp.122.5.509
• Schmidt, H. D., & Duman, R. S. (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant action and depression. Neurobiology of Disease, 26(3), 510–520. https://doi.org/10.1016/j.nbd.2007.01.012
• Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America, 93(9), 3908–3913. https://doi.org/10.1073/pnas.93.9.3908
• Snyder, J. S., Soumier, A., Brewer, M., Pickavance, J., & Cameron, H. A. (2011). Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature, 476(7361), 458–461. https://doi.org/10.1038/nature10287
• Sorrells, S. F., Paredes, M. F., Cebrian-Silla, A., Sandoval, K., Qi, D., Kelley, K. W., James, D., Mayer, S., Chang, J., Auguste, K. I., Chang, E. F., Gutiérrez, A. J., Kriegstein, A. R., Mathern, G. W., Oldham, M. C., Huang, E. J., Garcia-Verdugo, J. M., Yang, Z., & Alvarez-Buylla, A. (2018). Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature, 555(7696), 377–381. https://doi.org/10.1038/nature25975
• Spalding, K. L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H. B., Boström, E., Westerlund, I., Vial, C., Buchholz, B. A., Possnert, G., Mash, D. C., Druid, H., & Frisén, J. (2013). Dynamics of hippocampal neurogenesis in adult humans. Cell, 153(6), 1219–1227. https://doi.org/10.1016/j.cell.2013.05.015
• van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002). Functional neurogenesis in the adult hippocampus. Nature, 415(6875), 1030–1034. https://doi.org/10.1038/4151030a